[go: up one dir, main page]

AU599004B2 - Molecule comprising at least one peptidic sequence carrying an epitope - Google Patents

Molecule comprising at least one peptidic sequence carrying an epitope

Info

Publication number
AU599004B2
AU599004B2 AU45431/85A AU4543185A AU599004B2 AU 599004 B2 AU599004 B2 AU 599004B2 AU 45431/85 A AU45431/85 A AU 45431/85A AU 4543185 A AU4543185 A AU 4543185A AU 599004 B2 AU599004 B2 AU 599004B2
Authority
AU
Australia
Prior art keywords
epitope
molecule
sequence carrying
peptidic sequence
peptidic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU45431/85A
Other versions
AU4543185A (en
Inventor
Luiz Pereira Da Silva
Michael Koenen
Odile Mercereau-Puijalon
Benno Muller-Hill
Arthur Scherf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Publication of AU4543185A publication Critical patent/AU4543185A/en
Application granted granted Critical
Publication of AU599004B2 publication Critical patent/AU599004B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6893Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905Protozoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU45431/85A 1984-07-02 1985-07-02 Molecule comprising at least one peptidic sequence carrying an epitope Ceased AU599004B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8410461A FR2566780B1 (en) 1984-07-02 1984-07-02 MOLECULES COMPRISING AT LEAST ONE PEPTIDE SEQUENCE CARRYING A CHARACTERISTIC EPITOPE OF A PROTEIN PRODUCED BY CELLS INFECTED BY MALARIA PARASITES AND COMPOSITIONS CONTAINING THEM
FR8410461 1984-07-02

Publications (2)

Publication Number Publication Date
AU4543185A AU4543185A (en) 1986-02-10
AU599004B2 true AU599004B2 (en) 1990-07-12

Family

ID=9305696

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45431/85A Ceased AU599004B2 (en) 1984-07-02 1985-07-02 Molecule comprising at least one peptidic sequence carrying an epitope

Country Status (7)

Country Link
EP (1) EP0191028B1 (en)
AU (1) AU599004B2 (en)
CA (1) CA1268600A (en)
DE (1) DE3571442D1 (en)
FR (1) FR2566780B1 (en)
OA (1) OA08215A (en)
WO (1) WO1986000620A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231168A (en) * 1988-09-16 1993-07-27 Statens Seruminstitut Malaria antigen
PT100757A (en) * 1991-07-31 1993-10-29 Pasteur Institut POLYPEPTIDES FOR INDUCING "IN VIVO" ANTIBODIES ABLE TO INHIBIT THE INVASION OF RED GLOBULES BY MERZOITOS OF "P. FALCIPARUM", APARENTED PRODUCTS AND ITS APPLICATION IN THE PRODUCTION OF VACCINATION COMPOSITIONS
WO1993012145A1 (en) * 1991-12-19 1993-06-24 Baylor College Of Medicine Pva or peg conjugates of peptides for epitope-specific immunosuppression
US5532133A (en) * 1993-06-02 1996-07-02 New York University Plasmodium vivax blood stage antigens, PvESP-1, antibodies, and diagnostic assays
EP1544211A1 (en) 2003-12-15 2005-06-22 Institut Pasteur LSA-5 pre-erythrocytic stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4639985A (en) * 1984-07-23 1986-02-25 New York University Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
AU571202B2 (en) * 1983-01-28 1988-04-14 New York University Protective peptide antigen
AU596561B2 (en) * 1984-06-26 1990-05-10 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4442031A (en) * 1981-10-15 1984-04-10 Hoffmann-La Roche Inc. Immunopotentiating peptides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU571202B2 (en) * 1983-01-28 1988-04-14 New York University Protective peptide antigen
AU596561B2 (en) * 1984-06-26 1990-05-10 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
AU4639985A (en) * 1984-07-23 1986-02-25 New York University Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein

Also Published As

Publication number Publication date
DE3571442D1 (en) 1989-08-17
AU4543185A (en) 1986-02-10
EP0191028A1 (en) 1986-08-20
EP0191028B1 (en) 1989-07-12
WO1986000620A1 (en) 1986-01-30
CA1268600A (en) 1990-05-01
FR2566780A1 (en) 1986-01-03
OA08215A (en) 1987-10-30
FR2566780B1 (en) 1987-02-06

Similar Documents

Publication Publication Date Title
AU566235B2 (en) Atrial peptides
AU558258B2 (en) Immunogenic protein complex
AU5142485A (en) Cytotoxic protein
GB2155936B (en) Cyclosporins
AU9188982A (en) Interferon-like peptide
AU3937885A (en) Elektrische sicherheitssteckverbindung
AU546865B2 (en) Peptides
AU9188382A (en) Peptides
AU590016B2 (en) Peptides
AU572315B2 (en) Wafer
AU560305B2 (en) Plant-promoting preparations
GB8516281D0 (en) Peptides
DE3581337D1 (en) Peptide.
AU555831B2 (en) N-formyl-alpha-aspartylphenyl alanine
AU4628585A (en) Substituted phenylureas
DE3560261D1 (en) Peptides
AU599004B2 (en) Molecule comprising at least one peptidic sequence carrying an epitope
AU1643283A (en) Substituted peptides
AU4941385A (en) Antibiotic polypeptide
AU4027285A (en) Novel cyclosporins
AU595166B2 (en) Bellows
AU7412987A (en) Immunosuppressive protein
AU5029985A (en) Imidazopyridazine
AU5509194A (en) Hue sequence
AU7646981A (en) Antigenic peptide compound